Research Paper Volume 16, Issue 6 pp 5224—5248
Development and validation of a novel biomarker panel for Crohn’s disease and rheumatoid arthritis diagnosis and treatment
Figure 8. Validation of biomarker panel expression in CD lesions and normal tissues by q-PCR. Differential comparison of mRNA expression levels of CXCL10 (A), CXCL9 (B), SPP1 (C), AQP9 (D), and MT1M (E) in CD and normal tissues. **P < 0.01; ****P < 0.0001.